Statement Of Cash Flows [Abstract]

Ascelia Pharma - Filing #701899

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
77,000 SEK
87,000 SEK
Interest received, classified as operating activities
10,000 SEK
27,000 SEK
Income taxes paid (refund), classified as operating activities
1 020 SEK
89,000 SEK
Cash flows from (used in) operating activities
116 559 SEK
85 527 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
38,000 SEK
397,000 SEK
Cash flows from (used in) investing activities
38,000 SEK
75 991 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
200 000 SEK
98 653 SEK
Payments of lease liabilities, classified as financing activities
944,000 SEK
643,000 SEK
Cash flows from (used in) financing activities
184 871 SEK
92 725 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
68 274 SEK
83 189 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
8 639 SEK
7 019 SEK
Cash and cash equivalents
261 599 SEK
184 686 SEK
108 516 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.